LENSAR, Inc. (LNSR) News
Filter LNSR News Items
LNSR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LNSR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest LNSR News From Around the Web
Below are the latest news stories about LENSAR INC that investors may wish to consider to help them evaluate LNSR as an investment opportunity.
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 1,650 shares of the Company’s common stock. The options were granted as of January 2, 2025, as inducements material to each employee entering into employment with the Company. The options were granted in accordanc |
LENSAR, Inc.'s (NASDAQ:LNSR) Path To ProfitabilityWith the business potentially at an important milestone, we thought we'd take a closer look at LENSAR, Inc.'s... |
LENSAR to Participate in the BTIG 4th Annual Ophthalmology DayORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will participate in a fireside chat at the BTIG 4th Annual Ophthalmology Day on Monday, December 2, 2024 at 2 p.m. ET. Additionally, LENSAR management will host 1-on-1 meetings with institutional investors. BTIG hosted events ar |
LENSAR Third Quarter 2024 Earnings: Beats ExpectationsLENSAR ( NASDAQ:LNSR ) Third Quarter 2024 Results Key Financial Results Revenue: US$13.5m (up 38% from 3Q 2023). Net... |
LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ExpansionLENSAR Inc (LNSR) reports a 38% revenue increase and a 118% rise in ALLY system placements, despite challenges in gross margin and operating expenses. |
LENSAR Reports Third Quarter 2024 Results and Provides Business Update24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024 38% Revenue growth over third quarter 2023 and 22% Recurring revenue growth in twelve-month trailing average Worldwide procedure volumes increased 29% over third quarter of 2023 Installed system base grew 20% over third quarter of 2023 ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LENSAR®, Inc. (Nasdaq: LNSR) (“LENS |
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2024 financial results will be released before market open on Thursday, November 7, 2024. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, November 7, 2024 to discuss the financial results and re |
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth PlansEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Lensar announces more than 1M procedures completed with cataract laser systemsLENSAR announced that more than one million procedures have been performed using its technology. “We are proud to celebrate this significant milestone with our surgeon partners. Our mission is to bring innovative robotic laser solutions to cataract surgeons to help them improve clinical efficiencies and outcomes, while revolutionizing the patient and surgical experience,” said Nick Curtis, President and CEO of LENSAR. “The completion of our millionth procedure is a testament to our longstanding |
One Millionth Procedure Completed Using LENSAR’s Cataract Laser SystemsORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that more than one million procedures have been performed using its technology. “We are proud to celebrate this significant milestone with our surgeon partners. Our mission is to bring innovative robotic laser solutions to cataract surgeons to help them improve clin |